Intermittent Versus Daily Liraglutide: Equivalent Metabolic Efficacy With Reduced Gastrointestinal and Biliary Adverse Effects in Diet-Induced Obese Mice

Canadian Journal of Diabetes · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles